Publication: The majority of patients with HBeAg-negative chronic hepatitis B treated with peginterferon alpha-2a (40KD) [PEGASYS (R)] sustain responses 2 years post-treatment
No Thumbnail Available
Date
2006
Authors
Gürel, Selim
Authors
Marcellin, Patrick
Bonino, Ferruccio
Lau, George
Farci, Patrizia
Yurdaydin, C.
Piratvisuth, Teerha
Jin, R.
Hadziyannis, Stephanos J.
Lu, Zhimeng
Popescu, Madalina
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
Description
Bu çalışma, 26-30 Nisan 2006 tarihleri arasında Vienna[Avusturya]’da düzenlenen 41. Annual Meeting of the European-Association-for-the-Study-of-the-Liver’da bildiri olarak sunulmuştur.
Keywords
Gastroenterology & hepatology
Citation
Marcellin, P. vd. (2006). ''The majority of patients with HBeAg-negative chronic hepatitis B treated with peginterferon alpha-2a (40KD) [PEGASYS (R)] sustain responses 2 years post-treatment''. Journal of hepatology, 44(Suplement 2), S275-S275.